A given amino acid sequence can be encoded by a huge number of different nucleic acid sequences. These sequences, however, prove not to be equally useful. The choice of sequence can significantly impact the expression of an encoded protein. As regards the importance of protein-coding sequence and promising industrial and medicinal applications of Clostridium histolyticum collagenase, this study examined the codon optimization of the Col H gene so as to enhance collagenase expression in Escherichia coli (E. coli). The coding region of mature Col H gene was optimized according to the codon usage of E. coli using Gene Designer software (DNA 2.0). The results revealed that relative frequency of codon usage in Col H gene was adapted to the most preferred triplets in E. coli in such a way that codon usage bias in E. coli was enhanced after codon optimization. Similarly, the higher level of collagenase expression was more likely the result of substituting rare codons with optimal codons. As has been reported elsewhere, the findings from this study suggest that codon optimization provides a theoretical improvement in Col H gene expression in E. coli.
Introduction
Collagens that exist in a huge number of cell types are the integral component of animal tissues such as skin, tendons and cartilage as well as the organic constituent of bones, teeth and cornea.
In fact, it accounts for about 25 to 33% of the total protein in mammalian organs. Collagen which exists in the connective tissues of nearly all organs is as insoluble fibers. It imbeds in the mucopolysaccharides and protein of the extracellular matrix and plays a vital role in tissues strength (Harrington 1996) . A change in its production or degradation has been shown to result in a variety of diseases. In such cases, proteolytic enzymes provide a useful clinical way to the treatment of collagen-centered disorders. On the other hand, making use of enzymes as drug enjoys two advantages which differentiate them from all other types of drugs. To start with, enzymes frequently bind and act on their substrates with a high affinity. In the second place, enzymes are catalytic and transform target molecules into certain products. Thus, enzymes are more specific and potent drugs than small molecules that can accomplish therapeutic biochemistry in the body. These features have given rise to the development of many enzymatic drugs for a large variety of disorders (Vellard 2003) .
A tight triple helical structure that makes up collagen causes its resistance to most proteases; all the same, collagenases can specifically degrade collagen. Bacterial collagenases, in addition, have been shown to display broader substrate specificity than vertebrate collagenases.
Collagenases derived from Clostridium histolyticum, namely Col G and Col H, are a case in point since these are capable of easily digesting collagens, no matter what size and type they have (Ohbayashi, Yamagata et al. 2012; Preet Kaur and Azmi 2013) .
Recently, making use of Clostridium collagenases has attracted a great deal of researchers' interest as a non-invasive therapeutic procedure. As such, these collagenases have been examined for the treatment of Dupuytren's disease (Badalamente, Hurst et al. 2002 ), Peyronie's Disease (HELLSTROM and BIVALACQUA 2000) , Herniated Lumbar Disk (Sussman, Bromley et al. 1981) , retained placenta (Fecteau, Haffner et al. 1998) , adhesive capsulitis (Badalamente and Wang 2012) , wound healing (YAVUZER, LATİFOĞLU et al. 1997) ,the debridement of burns (Klasen 2000) and in the preparation of pancreatic islet cells for transplantation (Vrabelova, Adin et al. 2014 ).
Nowadays, culturing C. Histolyticum and subsequent purifying all of the produced bacterial proteins is a widely used method of producing collagenases for clinical applications (Bertuzzi, Cuttitta et al. 2014) . Nevertheless, the isolation and extraction of enzyme from natural sources due to low expression levels and the intracellular localization of enzyme faces technical problems and increases the costs of production. For commercial success, decreasing the cost of production is necessary which, in turn, depends on the expression level of enzyme and the purification costs.
As such, there has been growing interest in producing enzyme by recombinant methods (Katrolia, Yan et al. 2011) . Prokaryotic expression systems, especially E. coli, are one of the most common systems for the industrial production of proteins of therapeutic or commercial applications. E. coli has advantages including growth on inexpensive media, rapid biomass accumulation, convenient genetic manipulation, and simple scale-up (Baneyx and Mujacic 2004) . Nonetheless, the production of heterologous protein in the organism may be decreased by codon bias phenomenon, in which proteins of interest contain codons that are rarely used in E. coli (BurgessBrown, Sharma et al. 2008) . It has revealed that the presence of rare codons results in decreasing translation speed and inducing translational errors (Plotkin and Kudla 2010; Elena, Ravasi et al. 2014 ). The rarest codons in E. coli are illustrated in Table 1 . In addition to rare codons, GC content can affect expression levels. GC-rich mRNAs can contribute to forming powerful secondary structures and, especially in bacteria, such a powerful structure near ribosome-binding site obstructs translation initiation. On the other hand, GC-poor mRNAs cannot fold strongly and frequently carry sequence elements limiting expression. For instance, low GC content has been seen to restrict the expression of Plasmodium falciparum genes in E. coli. Such mRNAs seem to be targets for RNase E cleaving AU-rich sequence (Plotkin and Kudla 2010) . Codon optimization has been considered to be a common strategy to improve translation efficiency and accuracy (Gingold and Pilpel 2011) . Codon optimization, indeed, is to alter rare codons in target gene so as to adapt them to the codon usage of specific expression host. Recently, a huge number of studies have reported an increase in expression levels by codon optimization (Gustafsson, Govindarajan et al. 2004; Zhou, Schnake et al. 2004; Lee, Koh et al. 2010) . Here, we explored codon optimization of Col H gene to express in E. coli.
Material and methods:
Codon optimization of Col H The protein sequence of Col H was taken from UniProt database and 40 amino acids of putative signal peptide (MKRKCLSKRLMLAITMATIFTVNSTLPIYAAVDKNNATAA) were removed in order to generate a mature enzyme. Then, the coding region of mature Col H gene was optimized according to the codon usage of E. coli using Gene Designer software (DNA 2.0). This software using proprietary algorithms replaces rare codons and eliminates problematic mRNA structures and repetitive sequences.
Gene Sequence Analyses
The sequence analysis of native and optimized Col H gene was performed using online software involving Rare Codon Analysis Tool and Sequence Analysis which are available on web sites www.genscript.com and www.bioinformatics.org, respectively. 
Percentage of non-optimal and optimal codons before and after codon optimization
The native and optimized codon sequences of Col H enzyme are compared using Sequence Analysis software. The gene coding collagenase contains 2946 bp encoded the protein 982 amino acids. Before codon optimization, the numbers of rare codon GGA and GGG (codons encoding glycine) were 38 and 6, respectively. On the other hand, the codons GGC and GGT that are optimal for glycine were 3 and 26, respectively. After codon optimization, the rare codons reached 0 and the optimal codons GGC and GGT increased to 37 and 36, respectively. Moreover, the rare codons AGA and AGG (coding arginine) that were 23 and 5 fell to zero after optimization. In contrast, the codons CGT and CGC which are optimal for arginine increased from 2 and 1 to 20 and 11, respectively, after optimization. Additionally, the numbers of rare codons for leucine, i.e. TTA and CTA, decreased from 42 and 4 to zero. On the contrary, codon optimization raised the optimal codon CTG to 65. Furthermore, the codons AGT and TCA that are rare for serine diminished to zero and, in contrast, increased numbers in the optimal codons TCT, TCC, and AGC emerged from codon optimization. In addition, after codon optimization, the rare codon ACA encoding threonine declined from 23 to 0 and the optimal codon ACC increased from 4 to 40. As far as isoleucine amino acid is concerned, the rare codon ATA reduced from 41 to 0 and the optimal codons ATC and ATT rose to 35 and 23, respectively. As for proline, the rare codon CCC decreased from 1 to 0 and optimal codon CCG increased from 1 to 33. As to other amino acids, it has also been shown that codons biased towards more frequent codons via codon optimization. As an example, less frequent codon AAT that encode asparagine reduced from 57 to 10 and, contrarily, more frequent codon AAC increased from 12 to 59 (Table 2 )
Codon Adaption Index
Codon Adaption Index (CAI) assesses the extent of bias in favor of codons which are involved in highly expressed genes (Moriyama 2003) . The levels of protein expression and CAI are known to be correlated. A CAI of > 0.8 is regarded to be optimum for expression in the expression host of interest. As shown in Figure 2 , the CAI value for original gene was 0.62; however, codon optimization increased the CAI of the coding sequence to 0.84 that is ideal for expression in E.
coli.

Frequency of optimal codon
The simplest method for measuring species-specific codon usage bias is the frequency of optimal codons (Fop):
where Xop and Xnon are the number of optimal and non-optimal codons in a gene, respectively.
Codons excluded from the calculation contain stop codons and codons for tryptophan and methionine. Optimal codons for E. coli were originally determined based on the availability of tRNA and the nature of the codon-anticodon interplay. These codons are thought to be translationally optimal and are more frequently involved in genes expressed highly than lowly expressed genes (Moriyama 2003) . Non-optimal codon content is currently known to limit the expression of heterologous proteins owing to restricting available cognate tRNAs in the expression host (Angov 2011) . As can be seen from Figure 3 , the 44% of Col H codons showed the value of 100 before codon optimization whilst they increased to 64% with codon optimization. Additionally, the percentage of rare codons (codons with values lower than 30) was 12, which decreased to 0 following codon optimization.
GC content adjustment
Original gene encoding Col H showed a GC low content, resulting in low expression. In spite of that, codon optimization increased it from 30.99% to 47.46% (Figure 4 ).
Conclusion
In order to quantify translation efficiency, two measures are available. The first type of measures evaluates the codon bias of genes which CAI is a good case in point. A further kind is based on the availability of tRNA at each codon along the gene which Fop is a case in point. A privileged status of the Fop over the CAI is that it reduces the need to identify a set of highly expressed genes as a reference. On the contrary, it only needs the recognition of all tRNA genes in the genome and their classification in accordance with their anti-codon (Gingold and Pilpel 2011) .
Here, the Gene designer stand-alone software applied to optimize codons considers both methods. Furthermore, GC content in the Col H gene was balanced using the software. As such, better results are expected to have been obtained using the software.
As has been reported elsewhere [e.g. (Hu, Shi et al. 1996; Johansson, Bolton-Grob et al. 1999; Zhou, Schnake et al. 2004; Burgess-Brown, Sharma et al. 2008) ] the findings from this study suggest that codon optimization provides a theoretical improvement in Col H gene expression in E. coli. In spite of that, experimental research is needed to confirm the improvement. This is because although codon bias greatly impacts gene expression, it is not the only contributing factor. The selection of expression vectors and transcriptional promoters is also imperative (Gustafsson, Govindarajan et al. 2004 ). In addition, a sequence motif in the vicinity of the initiation AUG (Gingold and Pilpel 2011) and mRNA stability at the 5´terminus (Maertens, Spriestersbach et al. 2010) were shown to play a role in the gene expression.
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